- Home
- GEN vs HOLX Comparison
GEN vs HOLX Comparison
Compare GEN & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEN
- HOLX
- Stock Information
- Founded
- GEN 1982
- HOLX 1985
- Country
- GEN United States
- HOLX United States
- Employees
- GEN N/A
- HOLX N/A
- Industry
- GEN Computer Software: Prepackaged Software
- HOLX Medical Electronics
- Sector
- GEN Technology
- HOLX Health Care
- Exchange
- GEN Nasdaq
- HOLX Nasdaq
- Market Cap
- GEN 17.3B
- HOLX 16.3B
- IPO Year
- GEN N/A
- HOLX 1990
- Fundamental
- Price
- GEN $27.05
- HOLX $64.50
- Analyst Decision
- GEN Buy
- HOLX Buy
- Analyst Count
- GEN 4
- HOLX 14
- Target Price
- GEN $29.00
- HOLX $85.42
- AVG Volume (30 Days)
- GEN 3.4M
- HOLX 2.3M
- Earning Date
- GEN 01-30-2025
- HOLX 02-05-2025
- Dividend Yield
- GEN 1.85%
- HOLX N/A
- EPS Growth
- GEN N/A
- HOLX 50.83
- EPS
- GEN 1.02
- HOLX 3.16
- Revenue
- GEN $3,901,000,000.00
- HOLX $4,039,000,000.00
- Revenue This Year
- GEN $3.99
- HOLX $5.33
- Revenue Next Year
- GEN $3.43
- HOLX $5.72
- P/E Ratio
- GEN $26.54
- HOLX $20.44
- Revenue Growth
- GEN 3.12
- HOLX 1.76
- 52 Week Low
- GEN $19.58
- HOLX $62.70
- 52 Week High
- GEN $31.72
- HOLX $84.67
- Technical
- Relative Strength Index (RSI)
- GEN 41.91
- HOLX 34.25
- Support Level
- GEN $26.88
- HOLX $62.70
- Resistance Level
- GEN $28.09
- HOLX $65.18
- Average True Range (ATR)
- GEN 0.59
- HOLX 1.55
- MACD
- GEN -0.01
- HOLX -0.18
- Stochastic Oscillator
- GEN 31.82
- HOLX 17.36
About GEN Gen Digital Inc.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.